quantisnow
FeedTopReportsPricing
⌘K
Live feed
10:35:00·101d
PRRelease
ArriVent BioPharma Inc. logo
CG Oncology Inc. logo
Oncolytics Biotech Inc. logo
+2

Fast-Tracking the $537B Cancer Cure: How Accelerated Approvals Reshaping Oncology in 2026

AVBP· ArriVent BioPharma Inc.CGON· CG Oncology Inc.ONCY· Oncolytics Biotech Inc.PDSB· PDS Biotechnology CorporationZNTL· Zentalis Pharmaceuticals Inc.
Health Care
Original source

Companies

  • AVBP
    ArriVent BioPharma Inc.
    Health Care
  • CGON
    CG Oncology Inc.
    Health Care
  • ONCY
    Oncolytics Biotech Inc.
    Health Care
  • PDSB
    PDS Biotechnology Corporation
    Health Care
  • ZNTL
    Zentalis Pharmaceuticals Inc.
    Health Care

Recent analyst ratings

  • Mar 17ZNTLUpdateWells Fargo$5.00
  • Mar 12AVBPUpdateBTIG Research$42.00
  • Dec 11CGONUpdateWedbush$70.00
  • Dec 10AVBPUpdateBTIG Research$45.00
  • Nov 25AVBPUpdateTruist$43.00
  • Nov 24CGONUpdateTruist-

Related

  • PR2d
    Zentalis Pharmaceuticals Announces Abstract Acceptance at ASCO 2026 Featuring Azenosertib in Combination with Paclitaxel for Platinum-Resistant Ovarian Cancer
  • INSIDER3d
    SEC Form 4 filed by Mulay James
  • SEC6d
    SEC Form 144 filed by CG Oncology Inc.
  • PR6d
    Zentalis Pharmaceuticals To Present Azenosertib Preclinical Data in Triple-Negative Breast Cancer and Real-World Analysis of Unmet Need in Cyclin E1-Positive Ovarian Cancer at AACR 2026
  • SEC6d
    Zentalis Pharmaceuticals Inc. filed SEC Form 8-K: Regulation FD Disclosure, Financial Statements and Exhibits
  • INSIDER7d
    SEC Form 4 filed by Bellete Ambaw
  • INSIDER7d
    SEC Form 4 filed by Kasturi Vijay
  • INSIDER7d
    SEC Form 4 filed by Patterson Joshua F.
quantisnow

Real-time market intelligence for retail investors. Press releases, filings, ratings, and insider flow - all in one stream.

All systems operational

Feeds

Press releasesAnalyst ratingsInsider tradingFDASECRSS feeds

Top lists

TrendingBy market capActive companiesAnalyst upgradesInsider purchasesFDA approvalsSEC filingsSectorsMarket reports

Company

AboutPricingPublish with usContact

Legal

Terms of usePrivacy policyCookie policy

© 2026 quantisnow.com · Democratizing insights since 2022